DENTSPLY SIRONA (XRAY) director adds shares via RSU dividend equivalents

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Betsy D. Holden reported an automatic share acquisition tied to her existing equity awards. On January 9, 2026, she acquired 710.956 shares of common stock at a price of $0, reflecting dividends on her restricted stock units (RSUs) that were paid in the form of additional RSUs. These dividend RSUs carry the same vesting terms as the underlying awards, and each RSU converts into one share of common stock. Following this transaction, Holden beneficially owned 54,613.852 shares of DENTSPLY SIRONA common stock in direct ownership.

Insider Trade Summary

Net Buyer: 710.956 shares

Net Buy 1 txn

Insider HOLDEN BETSY D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	710.956	$0.00	$0.00

Holdings After Transaction: Common Stock — 54,613.852 shares (Direct)

Footnotes (1)

1. F1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report for Betsy D. Holden?

DENTSPLY SIRONA reported that director Betsy D. Holden acquired 710.956 shares of common stock on January 9, 2026, coded as an acquisition of non-derivative securities.

How did Betsy D. Holden receive the additional DENTSPLY SIRONA shares?

The 710.956 shares represent dividends on restricted stock units (RSUs) that were credited in the form of additional RSUs, which carry the same vesting terms as the original RSU awards.

Did Betsy D. Holden pay cash for the newly acquired DENTSPLY SIRONA (XRAY) shares?

No. The Form 4 shows a transaction price of $0 per share, as the shares were received through RSU dividend equivalents rather than a market purchase.

How many DENTSPLY SIRONA shares does Betsy D. Holden own after this transaction?

After the reported transaction, Betsy D. Holden beneficially owned 54,613.852 shares of DENTSPLY SIRONA common stock in direct ownership.

What is the vesting treatment of the RSU dividend equivalents for DENTSPLY SIRONA (XRAY)?

The RSU dividend equivalents are subject to the same vesting terms as the underlying RSUs. The dividends vest simultaneously with the related RSUs, and each RSU converts into one share of common stock.

What is Betsy D. Holden’s relationship to DENTSPLY SIRONA?

Betsy D. Holden is reported as a director of DENTSPLY SIRONA Inc. and is not listed as an officer or 10% owner in this Form 4.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/13/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOLDEN BETSY D

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		710.956(1)	A	$0	54,613.852	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Betsy D. Holden	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.